Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2025-09-05

Clinical Trial Update: Addressing Social Vulnerabilities in Cardiovascular Disease [NA]

View source ↗

Summary

A UCSF-sponsored clinical trial addressing social vulnerabilities in cardiovascular disease has been withdrawn. The study targeted congestive heart failure, isc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of California, San Francisco | Conditions: Congestive Heart Failure, Ischemic Heart Disease | NA | Status: WITHDRAWN